Valuation: SenesTech, Inc.

Market Cap 4.6M 4.11M 3.8M 3.44M 6.45M 437M 6.55M 45.77M 18.1M 229M 17.26M 16.89M 724M P/E 2026 *
-0.63x
P/E 2027 * -0.8x
Enterprise Value 4.6M 4.11M 3.8M 3.44M 6.45M 437M 6.55M 45.77M 18.1M 229M 17.26M 16.89M 724M EV / Sales 2026 *
1.32x
EV / Sales 2027 * 0.88x
Free-Float
95.74%
Yield 2026 *
-
Yield 2027 * -
1 day-1.85%
1 week+21.10%
Current month+25.27%
1 month+18.73%
3 months-39.01%
6 months-46.01%
Current year-60.39%
1 week 0.68
Extreme 0.68
0.86
1 month 0.55
Extreme 0.55
0.96
Current year 0.55
Extreme 0.55
2.53
1 year 0.55
Extreme 0.55
3.7
3 years 0.55
Extreme 0.55
45.6
5 years 0.55
Extreme 0.55
4,044
10 years 0.55
Extreme 0.55
512,880.82
Manager TitleAgeSince
Chief Executive Officer 62 06/05/2026
Director of Finance/CFO 65 01/09/2015
Chief Tech/Sci/R&D Officer - 01/11/2024
Director TitleAgeSince
Chairman 52 07/05/2026
Director/Board Member 53 05/11/2020
Director/Board Member 47 05/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
9/28/26 A Buy

Chief Executive Officer

2,000 0.0369%
9/14/26 A Buy

Chief Executive Officer

1,000 0.0184%
9/9/26 A Buy

Chief Executive Officer

2,000 0.0369%
Change 5-day change 1-year change 3-year change Capi.($)
-1.85%+21.10%-77.45%-97.72% 4.6M
+1.30%-2.30%+17.74%+23.42% 32.63B
+0.79%+1.97%+39.75%+50.54% 18.29B
-0.04%-3.30%-4.22%+37.11% 17.64B
+4.68%+6.01%-5.37%-8.63% 14.1B
+0.11%-.--%-.--%-.--% 12.96B
-0.81%+0.17%+7.30%+12.11% 11.1B
+2.96%-6.27%+2.62%+160.30% 9.8B
+0.59%-5.53% - - 7.97B
-0.22%-.--%-.--%-.--% 8.3B
Average +0.44%+0.74%-2.18%+19.68% 13.28B
Weighted average by Cap. +0.34%-1.38%+10.11%+31.46%

Financials

2026 *2027 *
Net sales 3.49M 3.12M 2.89M 2.61M 4.89M 332M 4.97M 34.73M 13.74M 174M 13.09M 12.82M 550M 5.24M 4.68M 4.33M 3.92M 7.34M 498M 7.47M 52.16M 20.63M 261M 19.66M 19.24M 825M
Net income -7.2M -6.44M -5.96M -5.4M -10.1M -685M -10.26M -71.71M -28.36M -358M -27.03M -26.46M -1.13B -6.22M -5.56M -5.14M -4.66M -8.71M -591M -8.86M -61.88M -24.48M -309M -23.33M -22.83M -979M
Net Debt - -
Projected Income Statement - Annual - SenesTech, Inc.
Logo SenesTech, Inc.
SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.
Employees
24
Date Price Change Volume
26/10/26 $0.8477 +0.92% 159,182
23/10/26 $0.8400 +5.13% 258,654
22/10/26 $0.7990 +6.53% 414,659
21/10/26 $0.7500 +8.81% 500,666
20/10/26 $0.6893 -1.53% 421,548
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - SenesTech, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8477USD
Average target price
7.500USD
Spread / Average Target
+784.75%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - SenesTech, Inc.
  1. Stock Market
  2. Stocks
  3. SNES Stock